Sanofi clinches 2nd bellwether win in chemotherapy hair loss litigationnews2021-11-22T15:40:19+00:00November 22nd, 2021|Fierce Pharma|
Pfizer, BioNTech ace long-term test of their COVID vaccine in kids 12 to 15, setting up likely approvalnews2021-11-22T14:28:46+00:00November 22nd, 2021|Fierce Pharma|
Sun Pharma yanks thousands of erectile dysfunction tablets after manufacturing mishapnews2021-11-22T14:03:11+00:00November 22nd, 2021|Fierce Pharma|
It’s a wrap: Merck collects enough Acceleron shares for $11.5B buyout despite activist investor defiancenews2021-11-22T10:22:27+00:00November 22nd, 2021|Fierce Pharma|
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?news2021-11-19T21:39:08+00:00November 19th, 2021|Fierce Pharma|
CDC vaccine advisers endorse Pfizer, Moderna COVID boosters for all adultsnews2021-11-19T20:41:30+00:00November 19th, 2021|Fierce Pharma|
FDA asks for 55 years to complete FOIA request on Pfizer’s COVID-19 vaccinenews2021-11-19T20:22:38+00:00November 19th, 2021|Fierce Pharma|
BioMarin’s dwarfism drug Voxzogo could be its next blockbuster, but ethics questions loom over the launchnews2021-11-19T16:18:26+00:00November 19th, 2021|Fierce Pharma|
Japan sees ‘drug lag’ as foreign pharmas pass up the market amid pricing pressure, industry group warnsnews2021-11-19T15:55:05+00:00November 19th, 2021|Fierce Pharma|
Pfizer, Moderna score FDA nods for COVID boosters in all adults, setting up high-stakes CDC meetingnews2021-11-19T14:53:56+00:00November 19th, 2021|Fierce Pharma|
